Target intelligence / Profile preview

Multiple epidermal growth factor-like domains 8 (MEGF8)

Target
MEGF8
Molecular classification
Single-pass transmembrane protein, Epidermal growth factor (EGF)-like domains, CUB domain, Kelch motif, Laminin EGF-like domain, PSI domain
01

Overview

Multiple epidermal growth factor-like domains 8 (MEGF8) is a large single-pass transmembrane protein encoded by the MEGF8 gene and composed of either 2845 or 2778 amino acids (human isoforms). It features a diverse set of domains, including several EGF-like domains known for their roles in protein-protein interactions and signaling, a CUB domain typically implicated in developmental processes, and motifs such as the kelch repeat and laminin EGF-like modules that influence protein structure and cellular interactions. MEGF8 is well conserved across animal species and is expressed during critical periods of development, contributing to body patterning and limb formation. Mutations in MEGF8 (particularly SNPs) are causative for Carpenter syndrome subtype 2, a rare congenital disorder with multisystem involvement. There is currently no evidence that MEGF8 acts as a direct pharmacological or therapeutic target, nor that it serves as a biomarker in clinical practice.

Other names
MEGF8Multiple epidermal growth factor-like domains 8C19orf49
02

Mechanism of action

Not applicable; drugs targeting MEGF8 are not reported

03

Biological functions

Developmental regulationCellular communicationLeft-right patterning (embryogenesis)Limb formation
04

Disease associations

Carpenter syndrome subtype 2 (SNP mutations in MEGF8 have been identified as a genetic cause)Developmental disorders (via regulation of morphogenic signaling pathways)

Beyond the preview

Go deeper on Multiple epidermal growth factor-like domains 8 (MEGF8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple epidermal growth factor-like domains 8 (MEGF8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call